Synchronized cell-cycle induction of engrafting long-term repopulating stem cells

We have recently defined the window for marrow stem cell homing into nonablated hosts as the first 24 hours posttransplant. Within this homing window, donor cells rapidly cleared from the peripheral blood and lungs and plateaued in the marrow. We have now assessed the cell-cycle status of the engraf...

Full description

Saved in:
Bibliographic Details
Published in:Blood 1997-12, Vol.90 (11), p.4646-4650
Main Authors: NILSSON, S. K, DOONER, M. S, QUESENBERRY, P. J
Format: Article
Language:English
Subjects:
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Animals
Antineoplastic Agents - pharmacology
Biological and medical sciences
Bone marrow, stem cells transplantation. Graft versus host reaction
Cell Count
Cell Cycle - drug effects
Female
Hematopoiesis - drug effects
Hematopoietic Stem Cell Transplantation
Hydroxyurea - pharmacology
In Situ Hybridization, Fluorescence
Male
Medical sciences
Mice
Mice, Inbred BALB C
Transfusions. Complications. Transfusion reactions. Cell and gene therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We have recently defined the window for marrow stem cell homing into nonablated hosts as the first 24 hours posttransplant. Within this homing window, donor cells rapidly cleared from the peripheral blood and lungs and plateaued in the marrow. We have now assessed the cell-cycle status of the engrafting cells capable of contributing to long-term hematopoiesis using administration of hydroxyurea (HU), a chemotherapy agent with S-phase cell-cycle specificity. HU was given at very short periods following a male bone marrow transplant (0, 3, 6, 12, and 15 hours) into female nonablated hosts, and donor cell engraftment was analyzed after 6 weeks. The data show that quickly after transplant (12 hours), greater than half of the engrafting cells capable of contributing long-term to all levels of the hematopoietic hierarchy are in S-phase. Analysis after 6 weeks included whole bone marrow, peripheral blood, primitive cells with high proliferative potential, and mature lineage-restricted marrow cells. These donor cells appear to be naturally synchronized. When HU was administered at any of the other time points, there was little evidence of cell death 6 weeks postengraftment.
ISSN:0006-4971
1528-0020
DOI:10.1182/blood.V90.11.4646